Year |
Citation |
Score |
2023 |
Witt RN, Nickel KS, Binns JR, Gray AM, Hintz AM, Kofron NF, Steigleder SF, Peterson FC, Veldkamp CT. NMR indicates the N-termini of PSGL1 and CCR7 bind competitively to the chemokine CCL21. Biochemistry and Biophysics Reports. 35: 101524. PMID 37554427 DOI: 10.1016/j.bbrep.2023.101524 |
0.466 |
|
2022 |
Brandum EP, Jørgensen AS, Calvo MB, Spiess K, Peterson FC, Yang Z, Volkman BF, Veldkamp CT, Rosenkilde MM, Goth CK, Hjortø GM. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails. International Journal of Molecular Sciences. 23. PMID 35163323 DOI: 10.3390/ijms23031397 |
0.601 |
|
2022 |
Lewandowski EM, Kroeck KG, Jacobs LMC, Fenske TG, Witt RN, Hintz AM, Ramsden ER, Zhang X, Peterson F, Volkman BF, Veldkamp CT, Chen Y. Structural Insights into Molecular Recognition by Human Chemokine CCL19. Biochemistry. PMID 35156805 DOI: 10.1021/acs.biochem.1c00759 |
0.68 |
|
2021 |
Jørgensen AS, Brandum EP, Mikkelsen JM, Orfin KA, Boilesen DR, Egerod KL, Moussouras NA, Vilhardt F, Kalinski P, Basse P, Chen YH, Yang Z, Dwinell MB, Volkman BF, Veldkamp CT, et al. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus. Cellular and Molecular Life Sciences : Cmls. PMID 34586443 DOI: 10.1007/s00018-021-03930-7 |
0.64 |
|
2021 |
Gutjahr JC, Crawford KS, Jensen DR, Naik P, Peterson FC, Samson GPB, Legler DF, Duchene J, Veldkamp CT, Rot A, Volkman BF. The dimeric form of CXCL12 binds to atypical chemokine receptor 1. Science Signaling. 14. PMID 34404752 DOI: 10.1126/scisignal.abc9012 |
0.648 |
|
2019 |
Jørgensen AS, Larsen O, Uetz-von Allmen E, Lückmann M, Legler DF, Frimurer TM, Veldkamp CT, Hjortø GM, Rosenkilde MM. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7. Frontiers in Immunology. 10: 2156. PMID 31572374 DOI: 10.3389/Fimmu.2019.02156 |
0.484 |
|
2018 |
Jørgensen AS, Adogamhe PE, Laufer JM, Legler DF, Veldkamp CT, Rosenkilde MM, Hjortø GM. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells. Journal of Leukocyte Biology. PMID 29768676 DOI: 10.1002/Jlb.2Vma0118-008R |
0.487 |
|
2017 |
Moussouras NA, Getschman AE, Lackner ER, Veldkamp CT, Dwinell MB, Volkman BF. Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands. International Journal of Molecular Sciences. 18. PMID 28869519 DOI: 10.3390/Ijms18091894 |
0.661 |
|
2017 |
Phillips AJ, Taleski D, Koplinski CA, Getschman AE, Moussouras NA, Richard AM, Peterson FC, Dwinell MB, Volkman BF, Payne RJ, Veldkamp CT. CCR7 Sulfotyrosine Enhances CCL21 Binding. International Journal of Molecular Sciences. 18. PMID 28841151 DOI: 10.3390/Ijms18091857 |
0.678 |
|
2017 |
Ziarek JJ, Kleist AB, London N, Raveh B, Montpas N, Bonneterre J, St-Onge G, DiCosmo-Ponticello CJ, Koplinski CA, Roy I, Stephens B, Thelen S, Veldkamp CT, Coffman FD, Cohen MC, et al. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation. Science Signaling. 10. PMID 28325822 DOI: 10.1126/Scisignal.Aah5756 |
0.778 |
|
2016 |
Smith EW, Lewandowski EM, Moussouras NA, Kroeck KG, Volkman BF, Veldkamp CT, Chen Y. Crystallographic structure of truncated CCL21 and putative sulfotyrosine-binding site. Biochemistry. PMID 27617343 DOI: 10.1021/Acs.Biochem.6B00304 |
0.693 |
|
2016 |
Barmore AJ, Castex SM, Gouletas BA, Griffith AJ, Metz SW, Muelder NG, Populin MJ, Sackett DM, Schuster AM, Veldkamp CT. Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding. Biochemical and Biophysical Research Communications. PMID 27338641 DOI: 10.1016/J.Bbrc.2016.06.098 |
0.496 |
|
2016 |
Veldkamp CT, Koplinski CA, Jensen DR, Peterson FC, Smits KM, Smith BL, Johnson SK, Lettieri C, Buchholz WG, Solheim JC, Volkman BF. Production of Recombinant Chemokines and Validation of Refolding. Methods in Enzymology. 570: 539-65. PMID 26921961 DOI: 10.1016/Bs.Mie.2015.09.031 |
0.554 |
|
2016 |
Seibert C, Sanfiz A, Sakmar TP, Veldkamp CT. Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes. Methods in Enzymology. 570: 357-88. PMID 26921955 DOI: 10.1016/Bs.Mie.2015.09.004 |
0.442 |
|
2016 |
Veldkamp CT, Koplinski CA, Jensen DR, Peterson FC, Smits KM, Smith BL, Johnson SK, Lettieri C, Buchholz WG, Solheim JC, Volkman BF. Production of Recombinant Chemokines and Validation of Refolding Methods in Enzymology. 570: 539-565. DOI: 10.1016/bs.mie.2015.09.031 |
0.426 |
|
2015 |
Kiermaier E, Moussion C, Veldkamp CT, Gerardy-Schahn R, de Vries I, Williams LG, Chaffee GR, Phillips AJ, Freiberger F, Imre R, Taleski D, Payne RJ, Braun A, Förster R, Mechtler K, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science (New York, N.Y.). PMID 26657283 DOI: 10.1126/Science.Aad0512 |
0.613 |
|
2015 |
Veldkamp CT, Kiermaier E, Gabel-Eissens SJ, Gillitzer ML, Lippner DR, DiSilvio FA, Mueller CJ, Wantuch PL, Chaffee GR, Famiglietti MW, Zgoba DM, Bailey AA, Bah Y, Engebretson SJ, Graupner DR, et al. Solution structure of CCL19 and identification of overlapping CCR7 and PSGL-1 binding sites. Biochemistry. PMID 26115234 DOI: 10.1021/Acs.Biochem.5B00560 |
0.489 |
|
2014 |
Casper SK, Schoeller SJ, Zgoba DM, Phillips AJ, Morien TJ, Chaffee GR, Sackett PC, Peterson FC, Crossgrove K, Veldkamp CT. The solution structure of the forkhead box-O DNA binding domain of Brugia malayi DAF-16a. Proteins. 82: 3490-6. PMID 25297652 DOI: 10.1002/Prot.24701 |
0.374 |
|
2014 |
Roy I, Veldkamp CT, Volkman BF, Dwinell MB. Chemokines in colitis: microRNA control. Gut. 63: 1202-4. PMID 24142964 DOI: 10.1136/Gutjnl-2013-305886 |
0.498 |
|
2013 |
Ziarek JJ, Veldkamp CT, Zhang F, Murray NJ, Kartz GA, Liang X, Su J, Baker JE, Linhardt RJ, Volkman BF. Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. The Journal of Biological Chemistry. 288: 737-46. PMID 23148226 DOI: 10.1074/Jbc.M112.394064 |
0.771 |
|
2012 |
Gerarden KP, Fuchs AM, Koch JM, Mueller MM, Graupner DR, O'Rorke JT, Frost CD, Heinen HA, Lackner ER, Schoeller SJ, House PG, Peterson FC, Veldkamp CT. Solution structure of the cold-shock-like protein from Rickettsia rickettsii. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 68: 1284-8. PMID 23143233 DOI: 10.1107/S174430911203881X |
0.303 |
|
2012 |
Love M, Sandberg JL, Ziarek JJ, Gerarden KP, Rode RR, Jensen DR, McCaslin DR, Peterson FC, Veldkamp CT. Solution structure of CCL21 and identification of a putative CCR7 binding site. Biochemistry. 51: 733-5. PMID 22221265 DOI: 10.1021/Bi201601K |
0.77 |
|
2011 |
Drury LJ, Ziarek JJ, Gravel S, Veldkamp CT, Takekoshi T, Hwang ST, Heveker N, Volkman BF, Dwinell MB. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. Proceedings of the National Academy of Sciences of the United States of America. 108: 17655-60. PMID 21990345 DOI: 10.1073/Pnas.1101133108 |
0.744 |
|
2011 |
Ziarek JJ, Heroux MS, Veldkamp CT, Peterson FC, Volkman BF. Sulfotyrosine recognition as marker for druggable sites in the extracellular space. International Journal of Molecular Sciences. 12: 3740-56. PMID 21747703 DOI: 10.3390/Ijms12063740 |
0.769 |
|
2010 |
Veldkamp CT, Ziarek JJ, Peterson FC, Chen Y, Volkman BF. Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design. Journal of the American Chemical Society. 132: 7242-3. PMID 20459090 DOI: 10.1021/Ja1002263 |
0.762 |
|
2009 |
Veldkamp CT, Ziarek JJ, Su J, Basnet H, Lennertz R, Weiner JJ, Peterson FC, Baker JE, Volkman BF. Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12. Protein Science : a Publication of the Protein Society. 18: 1359-69. PMID 19551879 DOI: 10.1002/Pro.167 |
0.755 |
|
2009 |
Volkman BF, Veldkamp CT, Peterson FC. Structure of SDF-1/CXCL12 Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.2210/Pdb2Kec/Pdb |
0.577 |
|
2008 |
Seibert C, Veldkamp CT, Peterson FC, Chait BT, Volkman BF, Sakmar TP. Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases Biochemistry. 47: 11251-11262. PMID 18834145 DOI: 10.1021/Bi800965M |
0.677 |
|
2008 |
Veldkamp CT, Seibert C, Peterson FC, De La Cruz NB, Haugner JC, Basnet H, Sakmar TP, Volkman BF. Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12 Science Signaling. 1. PMID 18799424 DOI: 10.1126/Scisignal.1160755 |
0.683 |
|
2008 |
Volkman BF, Veldkamp CT, Peterson FC. Structure of SDF1 in complex with the CXCR4 N-terminus containing sulfotyrosines at postitions 7, 12 and 21 Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.2210/Pdb2K05/Pdb |
0.579 |
|
2008 |
Volkman BF, Veldkamp CT, Peterson FC. Structure of SDF1 in complex with the CXCR4 N-terminus containing a sulfotyrosine at postition 21 Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.2210/Pdb2K03/Pdb |
0.579 |
|
2008 |
Volkman BF, Veldkamp CT, Peterson FC. Structure of a locked SDF1 dimer Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.2210/Pdb2K01/Pdb |
0.571 |
|
2007 |
Veldkamp CT, Peterson FC, Hayes PL, Mattmiller JE, Haugner JC, de la Cruz N, Volkman BF. On-column refolding of recombinant chemokines for NMR studies and biological assays. Protein Expression and Purification. 52: 202-9. PMID 17071104 DOI: 10.1016/J.Pep.2006.09.009 |
0.558 |
|
2006 |
Veldkamp CT, Seibert C, Peterson FC, Sakmar TP, Volkman BF. Recognition of a CXCR4 Sulfotyrosine by the Chemokine Stromal Cell-derived Factor-1α (SDF-1α/CXCL12) Journal of Molecular Biology. 359: 1400-1409. PMID 16725153 DOI: 10.1016/J.Jmb.2006.04.052 |
0.65 |
|
2005 |
Veldkamp CT, Peterson FC, Pelzek AJ, Volkman BF. The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Science : a Publication of the Protein Society. 14: 1071-81. PMID 15741341 DOI: 10.1110/Ps.041219505 |
0.626 |
|
Show low-probability matches. |